XNCR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.23%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,943,156.04

Xencor Insider Trading History Chart

Xencor Share Price & Price History

^$12.76

▼ -0.11 (-0.85%)

As of 03/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Xencor Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/4/2024	Alan Bruce Montgomery	Director	Sell	1,421	$27.03	$38,409.63	9,140
12/2/2024	Alan Bruce Montgomery	Director	Sell	13,301	$27.03	$359,526.03	9,140
11/21/2024	Bassil I Dahiyat	CEO	Sell	49,278	$24.07	$1,186,121.46	352,615
11/13/2024	Bassil I Dahiyat	CEO	Sell	3,366	$24.02	$80,851.32	352,615
11/11/2024	John R Desjarlais	VP	Sell	68,684	$23.48	$1,612,700.32	200,104
7/9/2024	John R Desjarlais	VP	Sell	36,329	$18.32	$665,547.28	192,319
3/11/2024	Bassil I Dahiyat	CEO	Sell	2,741	$23.50	$64,413.50	351,894
3/11/2024	Celia Eckert	SVP	Sell	850	$23.50	$19,975.00	45,465
3/11/2024	John J Kuch	CFO	Sell	849	$23.50	$19,951.50	121,070
3/11/2024	John R Desjarlais	VP	Sell	1,280	$23.50	$30,080.00	186,433
3/6/2024	Kurt A Gustafson	Director	Sell	14,000	$23.18	$324,520.00	6,007
3/5/2024	Bassil I Dahiyat	CEO	Sell	12,528	$23.43	$293,531.04	300,097
3/5/2024	Celia Eckert	SVP	Sell	3,892	$23.43	$91,189.56	33,226
3/5/2024	John J Kuch	CFO	Sell	4,474	$23.43	$104,825.82	121,919
3/5/2024	John R Desjarlais	VP	Sell	6,629	$23.43	$155,317.47	166,989
2/13/2024	John R Desjarlais	VP	Sell	54,108	$19.38	$1,048,613.04	161,675
12/29/2023	Bassil I Dahiyat	CEO	Sell	45,000	$20.93	$941,850.00	312,929
6/21/2023	Bassil I Dahiyat	CEO	Sell	33,497	$26.19	$877,286.43	292,216
3/9/2023	Allen Yang	CMO	Sell	1,094	$29.88	$32,688.72	73,364
3/9/2023	Bassil I Dahiyat	CEO	Sell	2,602	$29.88	$77,747.76	249,701
3/9/2023	Celia Eckert	VP	Sell	711	$29.88	$21,244.68	36,976
3/6/2023	Allen Yang	CMO	Sell	4,069	$31.42	$127,847.98	74,458
3/6/2023	Bassil I Dahiyat	CEO	Sell	5,831	$31.42	$183,210.02	252,303
3/6/2023	Celia Eckert	VP	Sell	2,462	$31.42	$77,356.04	37,687
3/6/2023	John J Kuch	CFO	Sell	2,774	$31.42	$87,159.08	126,941
3/3/2023	Bassil I Dahiyat	CEO	Sell	2,851	$31.54	$89,920.54	258,134
3/3/2023	Celia Eckert	VP	Sell	427	$31.54	$13,467.58	40,149
3/3/2023	John J Kuch	CFO	Sell	919	$31.54	$28,985.26	129,715
12/19/2022	Allen Yang	CMO	Sell	3,737	$27.00	$100,899.00	63,521

SEC Filings (Institutional Ownership Changes) for Xencor (NASDAQ:XNCR)

Institutional Buying and Selling by Quarter

Xencor Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2025	Mackenzie Financial Corp	4,390	$0.10M	0.0%	N/A	0.006%
2/19/2025	GF Fund Management CO. LTD.	1,469	$34K	0.0%	N/A	0.002%
2/19/2025	Public Employees Retirement System of Ohio	53,397	$1.23M	0.0%	N/A	0.076%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	321,308	$7.38M	0.0%	-3.5%	0.459%
2/17/2025	Woodline Partners LP	845,916	$19.44M	0.1%	+0.3%	1.209%
2/17/2025	Squarepoint Ops LLC	13,291	$0.31M	0.0%	-45.7%	0.019%
2/17/2025	Two Sigma Advisers LP	442,000	$10.16M	0.0%	-22.8%	0.632%
2/17/2025	Two Sigma Investments LP	297,223	$6.83M	0.0%	-36.7%	0.425%
2/17/2025	Teza Capital Management LLC	9,150	$0.21M	0.0%	N/A	0.013%
2/17/2025	Sherbrooke Park Advisers LLC	9,949	$0.23M	0.1%	N/A	0.014%
2/17/2025	Silvercrest Asset Management Group LLC	143,743	$3.30M	0.0%	-1.0%	0.205%
2/17/2025	RTW Investments LP	2,402,883	$55.22M	0.8%	+317.9%	3.434%
2/17/2025	Rafferty Asset Management LLC	51,976	$1.19M	0.0%	-19.1%	0.074%
2/17/2025	Point72 Asset Management L.P.	2,177,081	$50.03M	0.1%	-30.2%	3.111%
2/17/2025	ProShare Advisors LLC	23,638	$0.54M	0.0%	-26.6%	0.034%
2/17/2025	Nuveen Asset Management LLC	837,082	$19.24M	0.0%	+452.4%	1.196%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	39,040	$0.90M	0.1%	+22.0%	0.056%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	40,355	$0.93M	0.0%	+23.4%	0.058%
2/17/2025	Jacobs Levy Equity Management Inc.	519,976	$11.95M	0.0%	+150.4%	0.743%
2/17/2025	Deutsche Bank AG	58,041	$1.33M	0.0%	+53.1%	0.083%
2/17/2025	Deep Track Capital LP	500,000	$11.49M	0.4%	-37.5%	0.714%
2/17/2025	Braidwell LP	615,531	$14.15M	0.4%	+32.0%	0.880%
2/17/2025	BVF Inc. IL	2,288,760	$52.60M	1.8%	+169.3%	3.271%
2/17/2025	Bayesian Capital Management LP	8,716	$0.20M	0.0%	-19.4%	0.012%
2/17/2025	Bank of America Corp DE	33,507	$0.77M	0.0%	-94.6%	0.048%
2/17/2025	BNP Paribas Financial Markets	16,528	$0.38M	0.0%	+23.7%	0.024%
2/17/2025	Ameriprise Financial Inc.	292,576	$6.72M	0.0%	+72.4%	0.418%
2/14/2025	Jane Street Group LLC	35,437	$0.81M	0.0%	-79.0%	0.051%
2/14/2025	Comerica Bank	20,527	$0.47M	0.0%	+12.1%	0.029%
2/14/2025	TCG Crossover Management LLC	2,452,138	$56.35M	5.5%	+1.0%	3.504%
2/14/2025	Northern Trust Corp	747,152	$17.17M	0.0%	+19.3%	1.068%
2/14/2025	The Manufacturers Life Insurance Company	100,373	$2.31M	0.0%	-8.5%	0.143%
2/14/2025	Aquatic Capital Management LLC	10,227	$0.24M	0.0%	N/A	0.015%
2/14/2025	Birchview Capital LP	26,000	$0.60M	0.5%	+111.4%	0.037%
2/14/2025	Virtus ETF Advisers LLC	2,871	$66K	0.0%	-33.6%	0.004%
2/14/2025	Nebula Research & Development LLC	9,826	$0.23M	0.0%	-51.8%	0.014%
2/14/2025	Voya Investment Management LLC	38,118	$0.88M	0.0%	-24.1%	0.054%
2/14/2025	Syon Capital LLC	9,745	$0.22M	0.0%	N/A	0.014%
2/14/2025	Price T Rowe Associates Inc. MD	4,036,412	$92.76M	0.0%	+2.7%	5.768%
2/14/2025	Tower Research Capital LLC TRC	7,865	$0.18M	0.0%	+132.5%	0.011%
2/14/2025	MetLife Investment Management LLC	40,740	$0.94M	0.0%	+16.9%	0.058%
2/14/2025	Dimensional Fund Advisors LP	1,501,532	$34.51M	0.0%	+7.3%	2.146%
2/13/2025	CANADA LIFE ASSURANCE Co	83,535	$1.92M	0.0%	+11.0%	0.119%
2/13/2025	XTX Topco Ltd	18,582	$0.43M	0.0%	-15.8%	0.027%
2/13/2025	Barclays PLC	330,745	$7.60M	0.0%	+112.6%	0.473%
2/13/2025	Summit Investment Advisors Inc.	7,045	$0.16M	0.1%	+22.2%	0.010%
2/13/2025	Sterling Capital Management LLC	1,182	$27K	0.0%	+732.4%	0.002%
2/13/2025	Raymond James Financial Inc.	101,346	$2.33M	0.0%	N/A	0.145%
2/13/2025	Capula Management Ltd	13,120	$0.30M	0.0%	N/A	0.019%
2/13/2025	Legal & General Group Plc	191,514	$4.40M	0.0%	+11.8%	0.274%
2/13/2025	Invesco Ltd.	454,745	$10.45M	0.0%	-25.6%	0.650%
2/13/2025	ADAR1 Capital Management LLC	234,607	$5.39M	1.1%	-31.5%	0.335%
2/13/2025	Bank of Montreal Can	10,408	$0.24M	0.0%	N/A	0.015%
2/13/2025	Finepoint Capital LP	660,000	$15.17M	0.9%	N/A	0.943%
2/13/2025	Russell Investments Group Ltd.	216,291	$4.97M	0.0%	-7.2%	0.309%
2/13/2025	Rhenman & Partners Asset Management AB	195,750	$4.50M	0.5%	-3.9%	0.280%
2/13/2025	Wells Fargo & Company MN	36,086	$0.83M	0.0%	+50.7%	0.052%
2/12/2025	Trexquant Investment LP	83,241	$1.91M	0.0%	-59.6%	0.119%
2/12/2025	Geode Capital Management LLC	1,634,876	$37.58M	0.0%	+12.3%	2.336%
2/12/2025	Franklin Resources Inc.	195,452	$4.49M	0.0%	+3.7%	0.279%
2/12/2025	Alliancebernstein L.P.	72,090	$1.66M	0.0%	-4.2%	0.103%
2/12/2025	Wellington Management Group LLP	27,491	$0.63M	0.0%	N/A	0.039%
2/12/2025	Pictet Asset Management Holding SA	10,740	$0.25M	0.0%	N/A	0.015%
2/12/2025	Norges Bank	147,823	$3.40M	0.0%	N/A	0.211%
2/12/2025	Loomis Sayles & Co. L P	1,092,346	$25.10M	2.7%	+21.3%	1.561%
2/12/2025	JPMorgan Chase & Co.	121,063	$2.78M	0.0%	-7.1%	0.173%
2/12/2025	WINTON GROUP Ltd	53,705	$1.23M	0.1%	-3.7%	0.077%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	10,657	$0.26M	0.0%	-6.8%	0.015%
2/11/2025	Prudential Financial Inc.	70,715	$1.63M	0.0%	+10.7%	0.101%
2/11/2025	Corebridge Financial Inc.	35,946	$0.83M	0.0%	+5.1%	0.051%
2/11/2025	Advantage Alpha Capital Partners LP	13,548	$0.31M	0.1%	-45.5%	0.019%
2/11/2025	Vanguard Group Inc.	8,017,366	$184.24M	0.0%	+5.5%	11.457%
2/11/2025	LPL Financial LLC	19,680	$0.45M	0.0%	+12.0%	0.028%
2/11/2025	KLP Kapitalforvaltning AS	12,200	$0.28M	0.0%	N/A	0.017%
2/11/2025	American Century Companies Inc.	114,231	$2.63M	0.0%	+11.1%	0.163%
2/11/2025	DCF Advisers LLC	203,167	$4.67M	2.3%	-3.0%	0.290%
2/11/2025	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	14,940	$0.34M	0.0%	+13.0%	0.021%
2/11/2025	Teacher Retirement System of Texas	18,645	$0.43M	0.0%	+21.1%	0.027%
2/11/2025	Maryland State Retirement & Pension System	23,567	$0.54M	0.0%	+12.9%	0.034%
2/10/2025	Thrivent Financial for Lutherans	122,897	$2.82M	0.0%	+5.6%	0.176%
2/10/2025	Primecap Management Co. CA	8,984,432	$206.46M	0.2%	-1.7%	12.839%
2/10/2025	Swiss National Bank	123,600	$2.84M	0.0%	+3.0%	0.177%
2/7/2025	Amundi	35,380	$0.83M	0.0%	+225.0%	0.051%
2/7/2025	PNC Financial Services Group Inc.	4,041	$93K	0.0%	+49.4%	0.006%
2/6/2025	Raymond James Financial Inc.	101,346	$2.33M	0.0%	N/A	0.145%
2/6/2025	Arizona State Retirement System	18,190	$0.42M	0.0%	+13.3%	0.026%
2/6/2025	Charles Schwab Investment Management Inc.	630,640	$14.49M	0.0%	+0.6%	0.901%
2/5/2025	US Bancorp DE	2,532	$58K	0.0%	-75.6%	0.004%
2/5/2025	Mutual of America Capital Management LLC	10,600	$0.24M	0.0%	N/A	0.015%
2/5/2025	Oregon Public Employees Retirement Fund	16,512	$0.38M	0.0%	+13.8%	0.024%
2/4/2025	Illinois Municipal Retirement Fund	33,198	$0.76M	0.0%	+25.8%	0.047%
2/4/2025	Amalgamated Bank	20,243	$0.47M	0.0%	+11.1%	0.029%
2/4/2025	Bank of New York Mellon Corp	437,152	$10.05M	0.0%	+4.4%	0.625%
2/3/2025	Handelsbanken Fonder AB	26,600	$0.61M	0.0%	+14.2%	0.038%
1/31/2025	Sanctuary Advisors LLC	28,263	$0.65M	0.0%	+5.3%	0.040%
1/31/2025	Principal Financial Group Inc.	340,145	$7.82M	0.0%	+16.5%	0.486%
1/31/2025	Baillie Gifford & Co.	20,898	$0.48M	0.0%	-9.9%	0.030%
1/30/2025	Rhumbline Advisers	170,000	$3.91M	0.0%	+11.7%	0.243%
1/29/2025	Louisiana State Employees Retirement System	33,800	$0.78M	0.0%	+13.0%	0.048%
1/28/2025	Essex LLC	113,661	$2.61M	0.5%	-14.3%	0.162%

Data available starting January 2016

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It develops Plamotamab, a bispecific antibody, which is in Phase I clinical trial to treat non-Hodgkin lymphoma; Vudalimab, a bispecific antibody, which is in Phase II clinical trial to treat metastatic castration-resistant prostate cancer and other solid tumor types. The company is also developing XmAb306, which is in Phase I clinical trial to treat solid tumors; XmAb104, which is in Phase II clinical trial to treat patients with selected solid tumors; XmAb564 that is in Phase Ia clinical trial to treat autoimmune diseases; AMG 509, which is in Phase I clinical trial to treat prostate cancer; XmAb819 for patients with renal cell carcinoma; XmAb541 for the treatment of ovarian cancer; and XmAb662 which is in Phase I clinical trial to treat patients with solid tumors. In addition, the company develops VIR-3434, which is in Phase II clinical trial for patients with hepatitis B virus infection; and VIR-2482 that is in Phase 2 clinical trial to trat hepatitis B virus. The company develops AIMab7195 to reduce blood serum levels of IgE that mediates allergic responses and allergic disease; Obexelimab to treat autoimmune disease; and Xpro1595 to treat patients with Alzheimer's disease, and depression. It has a license agreement with Caris Life Sciences. Xencor, Inc. was incorporated in 1997 and is headquartered in Pasadena, California.

Today's Range

Now: $12.76

$12.69

$13.12

50 Day Range

MA: $17.36

$12.76

$23.94

52 Week Range

Now: $12.76

$12.69

$27.24

Volume

723,182 shs

Average Volume

551,783 shs

Market Capitalization

$899.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Who are the company insiders with the largest holdings of Xencor?: Xencor's top insider investors include:
Bassil I Dahiyat (CEO)
John R Desjarlais (VP)
John J Kuch (CFO)
Celia Eckert (SVP)
Alan Bruce Montgomery (Director)
Kurt A Gustafson (Director)
Learn More about top insider investors at Xencor.
Who are the major institutional investors of Xencor?: Xencor's top institutional investors include:
Primecap Management Co. CA — 12.84%
Vanguard Group Inc. — 11.46%
Price T Rowe Associates Inc. MD — 5.77%
TCG Crossover Management LLC — 3.50%
RTW Investments LP — 3.43%
BVF Inc. IL — 3.27%
Learn More about top institutional investors of Xencor stock.
Which institutional investors are selling Xencor stock?: During the last quarter, XNCR stock was sold by these institutional investors:
Point72 Asset Management L.P.
Bank of America Corp DE
Deep Track Capital LP
Two Sigma Investments LP
Invesco Ltd.
Primecap Management Co. CA
Jane Street Group LLC
Two Sigma Advisers LP
In the last year, company insiders that have sold Xencor company stock include:
Bassil I Dahiyat (CEO)
John R Desjarlais (VP)
John J Kuch (CFO)
Learn More investors selling Xencor stock.
Which institutional investors are buying Xencor stock?: During the previous quarter, XNCR stock was purchased by institutional investors including:
RTW Investments LP
BVF Inc. IL
Nuveen Asset Management LLC
Finepoint Capital LP
Vanguard Group Inc.
Jacobs Levy Equity Management Inc.
Loomis Sayles & Co. L P
Geode Capital Management LLC